Be at the Core of Circular and Self-Amplifying RNA Innovation
Why Partner?
The Circular and Self-Amplifying RNA Therapeutics Summit offers solution providers a rare opportunity to engage directly with the companies defining the future of RNA medicine. As circRNA and saRNA programs progress from platform validation to IND-enabling execution, developers are actively seeking external partners to solve challenges across material quality, delivery optimization, preclinical validation, and clinical readiness.
This summit convenes senior scientists, platform leaders, and decision-makers from biotech and pharma who are responsible for selecting vendors that can support durability, redosing, manufacturability, and regulatory alignment. With a focused audience and a single-community format, conversations move beyond theory and into practical outsourcing decisions.
By partnering, your brand is positioned at the center of critical discussions around RNA synthesis, formulation development, preclinical testing, and translational strategy.
Extensive built-in networking, targeted meeting opportunities, and high visibility across the event ensure you connect with the teams actively building and scaling circular and self-amplifying RNA pipelines.
Whether you provide foundational materials, development services, or advanced delivery solutions, this is your opportunity to support programs moving toward the clinic and become a trusted partner in next-generation RNA therapeutics.
What to Expect?
Meet New Clients
Engage face-to-face with biotech founders, translational scientists, and pharma leaders who are actively sourcing reagents, CRO support, formulation expertise, and development partners.
Position Your Brand Within RNA Innovation
Increase visibility across the summit website, brochure, and onsite experience, placing your brand alongside the companies advancing circular and self-amplifying RNA into the clinic.
Demonstrate Your Expertise
Showcase your capabilities through speaking opportunities, exhibition spaces, workshops, and targeted networking aligned to the summit’s highly technical agenda.
Gain Strategic Market Insights
Hear directly from leading RNA developers such as Strand, Replicate, and Sail Biomedicines to understand evolving requirements around synthesis quality, delivery optimization, preclinical validation, and IND readiness.
Key Services & Solutions
Our attendees from next-generation RNA biopharma are looking for service and solution providers with capabilities in, but not limited to, the below areas:
- Reagents, Enzymes, and RNA Building Blocks
Support RNA development with high-purity modified nucleotides, IVT enzymes, capping reagents, and specialty chemistries. - Plasmid DNA and Template Manufacturing
Provide GMP and research-grade plasmid DNA production to enable scalable circRNA and saRNA workflows. - RNA Synthesis and Process Development
Enable robust RNA production through IVT optimization, circularization strategies, and quality analytics. - Delivery System Research and Optimization
Support formulation design through lipid library screening, polymer systems, and microfluidics-based R and D platforms. - Preclinical CRO Services
Deliver in vitro and in vivo studies including expression durability, biodistribution, immunogenicity, and GLP toxicology. - Clinical Development and Trial Execution
Manage early-phase clinical trials, biostatistics, clinical operations, and regulatory submissions. - CMC and Regulatory Support Services
Guide IND-enabling strategy with expertise in analytical development, comparability, and regulatory documentation. - Manufacturing Scale-Up and Tech Transfer
Assist with transition from research to GMP production, including process scale-up and manufacturing readiness.
Hear What Our Past Attendees Have to Say
It was a great meeting to network with thought leaders and learn about RNA therapeutics, their promise, and the challenges they face.
Anitaben Tailor, Global Technical Marketing Manager, Merck KGaA
Great opportunity to connect with science and the field in general.
Nathaniel Wang, Chief Executive Officer & Co-Founder, Replicate Bioscience
A great opportunity to learn and to network; bought together stakeholders from virtually all aspects of RNA therapeutics.
James Ferguson, Chief Medical Officer, Matinas BioPharma
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Maddie Woodside
Business Development Manager